BCYC Q4 2019 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+399.6% YoY

Gross Profit

-$1M-25.9% margin

Operating Income

-$5M-90.2% margin

Net Income

-$4M-83.4% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+760.1%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$110M

Total Liabilities

$17M

Stockholders' Equity

$93M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$1M	+399.6%
Gross Profit	-$1M	-$5M	+74.8%
Operating Income	-$5M	-$8M	+36.8%
Net Income	-$4M	-$7M	+33.7%